U.S. flag An official website of the United States government
  1. Home
  2. Science & Research
  3. About Science & Research at FDA
  4. Decomposition of Seafood Products by Mass Spectrometry with Sensory-Driven Predictive Modeling - 11/08/2018 - 11/08/2018
  1. About Science & Research at FDA

Webcast | Virtual

Event Title
Decomposition of Seafood Products by Mass Spectrometry with Sensory-Driven Predictive Modeling
November 8, 2018

Date:
November 8, 2018

Prior FDA Grand Rounds presentation

Presented by

Randy Self
Research Chemist
Applied Technology Center
FDA's Office of Regulatory Affairs
Pacific Northwest Laboratory

Webcast Lecture

Decomposition of Seafood Products by Mass Spectrometry with Sensory-Driven Predictive Modeling

About the Presentation

Sensory analysis is performed in FDA testing laboratories to determine the decomposition status of seafood samples. Current methodology to complement this testing with chemical analysis (e.g., histamine) is not always directly comparable to sensory testing.

The presentation will discuss a novel method that FDA is exploring with untargeted analysis and a statistical model driven by sensory results via a script written in the R programming language. This enables generation of data that are directly comparable to commonly used sensory scoring techniques.

The method was applied to six species of salmon, across a wide range of decomposition conditions. Accuracy and reproducibility of the method in comparison with sensory results were demonstrated, and show promising results. Since it generates data which are comparable to sensory analysis, it provides a potentially useful companion to that work. Implementation of this technique stands to open an additional avenue for this type of analysis, aiding the agency’s public health mission with increased coverage of this issue.

About the Presenter

Randy Self is a research chemist with FDA’s Applied Technology Center in the Pacific Northwest Laboratory, where he conducts research on method development for food safety applications. His work focuses primarily on development of novel high-resolution mass spectrometry techniques.  Randy has been with FDA since 2001, serving as a regulatory chemist at the Pacific Northwest Laboratory before joining the Agency's Applied Technology Center. 

 
Back to Top